blonanserin has been researched along with ngb 2904 in 1 studies
| Studies (blonanserin) | Trials (blonanserin) | Recent Studies (post-2010) (blonanserin) | Studies (ngb 2904) | Trials (ngb 2904) | Recent Studies (post-2010) (ngb 2904) |
|---|---|---|---|---|---|
| 121 | 21 | 93 | 34 | 0 | 16 |
| Protein | Taxonomy | blonanserin (IC50) | ngb 2904 (IC50) |
|---|---|---|---|
| Integrin beta-3 | Homo sapiens (human) | 0.005 | |
| Integrin alpha-IIb | Homo sapiens (human) | 0.005 | |
| D(2) dopamine receptor | Homo sapiens (human) | 1.28 | |
| D(3) dopamine receptor | Homo sapiens (human) | 0.0113 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Huang, M; Kwon, S; Meltzer, HY; Miyauchi, M; Oyamada, Y; Rajagopal, L | 1 |
1 other study(ies) available for blonanserin and ngb 2904
| Article | Year |
|---|---|
Dopamine D3 receptor antagonism contributes to blonanserin-induced cortical dopamine and acetylcholine efflux and cognitive improvement.
Topics: Acetylcholine; Animals; Benzopyrans; Brain Chemistry; Cerebral Cortex; Dopamine; Dopamine Antagonists; Excitatory Amino Acid Antagonists; Fluorenes; Haloperidol; Male; Mice; Mice, Inbred C57BL; Nootropic Agents; Oxazines; Phencyclidine; Piperazines; Piperidines; Rats, Long-Evans; Receptors, Dopamine D3 | 2015 |